Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Healthcare Triangle, Inc. incurred convertible notes of $2,000,000 with institutional investor at 18% maturing 18 months after issuance.
- Instrument
- convertible notes
- Principal
- $2,000,000
- Counterparty
- institutional investor
- Rate
- 18%
- Maturity
- 18 months after issuance
- Event
- incurrence
Exact text from the filing
greement (the “ Purchase Agreement ”) with an institutional investor (the “ Investor ”), pursuant to which the Company agreed to issue to the Investor Senior Secured 15% Original Issue Discount Convertible Promissory Notes (the “ Notes ”)
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Healthcare Triangle, Inc. entered into Securities Purchase Agreement with institutional investor valued at Aggregate principal amount up to $5,200,000; gross proceeds up to $4,420,000 (effective 2023-12-28).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- institutional investor
- Value
- Aggregate principal amount up to $5,200,000; gross proceeds up to $4,420,000
- Effective
- 2023-12-28
Exact text from the filing
On December 28, 2023, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with an institutional investor (the “ Investor ”), pursuant to which the Company agreed to issue to the Investor Senior Secured 15% Original Issue Discount Convertible Promissory Notes (the “ Notes ”) in the aggregate principal amount of up to $5,200,000 which will result in gross proceeds to the Company in the amount of up to $4,420,000 due to the original issue discount, and warrants (the “ Warrants ”) to purchase a number of shares of the Company’s common stock (the “ Warrant Shares ”) equal to 50% of the face value of the Notes divided by the volume weighted average price, in three tranches (such transaction, the “ Private Placement ”).
View on SEC.gov